SearchStrings |
1 | 9160 | 75.73 | &esrc=s |
2 | 147 | 1.22 | tropical journal of pharmaceutical resea... |
3 | 52 | 0.43 | 1 |
4 | 30 | 0.25 | tjpr |
5 | 30 | 0.25 | tropical journal |
6 | 29 | 0.24 | cyclodextrine pdf |
7 | 22 | 0.18 | pharmaceutical validation |
8 | 20 | 0.17 | solid lipid nanoparticles |
9 | 20 | 0.17 | doses extract piper crocatum |
10 | 20 | 0.17 | inorganic nanoparticles in drug delivery |
11 | 18 | 0.15 | filetype:pdf curcumin, piperine, hplc |
12 | 18 | 0.15 | 99350103 |
13 | 17 | 0.14 | (Google Cache) |
14 | 16 | 0.13 | amleoration of cisplatin induced nephrot... |
15 | 15 | 0.12 | sana ghayas |
16 | 13 | 0.11 | effect of anionic polymers on drug loadi... |
17 | 12 | 0.10 | polygonum |
18 | 12 | 0.10 | nanoparticles and their application in d... |
19 | 12 | 0.10 | microcrystalline cellulose properties pd... |
20 | 12 | 0.10 | pentapeptide induced apoptosis |
21 | 11 | 0.09 | http://www.tjpr.org/vol1%20no2/okhamafe1... |
22 | 11 | 0.09 | marketed bioadhesive diclofenac |
23 | 11 | 0.09 | international journal of nanomedicine 20... |
24 | 11 | 0.09 | validation in pharma |
25 | 11 | 0.09 | tjpr journal |
26 | 11 | 0.09 | synthesis of nano drug |
27 | 11 | 0.09 | bioavailability studies of odts in human... |
28 | 10 | 0.08 | gold nanoparticles pdf |
29 | 10 | 0.08 | anti-inflammatory activity of lamiacea f... |
30 | 10 | 0.08 | nanoparticles pdf |
31 | 10 | 0.08 | polygonum amplexicaule whitening effect ... |
32 | 10 | 0.08 | nanoparticle drug delivery system?q=nano... |
33 | 9 | 0.07 | controlled drug release skin |
34 | 9 | 0.07 | nlc topical |
35 | 9 | 0.07 | khan nanotechnology paper 2006 |
36 | 9 | 0.07 | http://www.tjpr.org/vol13_no10/2014_13_1... |
37 | 8 | 0.07 | proniosomes |
38 | 8 | 0.07 | evolution of pharmacist practice in nige... |
39 | 8 | 0.07 | evaluation of anti oxidant pdf |
40 | 8 | 0.07 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
41 | 8 | 0.07 | nanoparticles delivery method |
42 | 8 | 0.07 | 'inclusion complexes' |
43 | 8 | 0.07 | http://www.tjpr.org/vol8_no2/2009_8_2_11... |
44 | 8 | 0.07 | &sa=search |
45 | 7 | 0.06 | cache:http://www.tjpr.org/vol10_no4/2011... |
46 | 7 | 0.06 | http://www.tjpr.org/vol10_no5/2011_10_5_... |
47 | 7 | 0.06 | inorganic gold nano particles |
48 | 7 | 0.06 | tea pdf |
49 | 7 | 0.06 | pharmaeuical compound using turbidity |
50 | 7 | 0.06 | pharma validation |
51 | 7 | 0.06 | disintegration of furasmide tablet |
52 | 7 | 0.06 | solanum nigrum linn berries pdf |
53 | 7 | 0.06 | http://www.tjpr.org/vol13_no10/2014_13_1... |
54 | 6 | 0.05 | 85409dd0d58db8a0bb1ffd4217268b78 |
55 | 6 | 0.05 | morinda citrifolia kidney |
56 | 6 | 0.05 | raw treated lps catechin |
57 | 6 | 0.05 | sana ghayas 2014 |
58 | 6 | 0.05 | http://www.tjpr.org/vol8_no3/2009_8_3_8_... |
59 | 6 | 0.05 | natural penetration enhancer transdermal... |
60 | 6 | 0.05 | multiparticulate system |
61 | 6 | 0.05 | tramadol hydrochloride dispersible table... |
62 | 6 | 0.05 | irrational use of nsaids by pharmacists ... |
63 | 6 | 0.05 | chemical properties of essential oils |
64 | 6 | 0.05 | tea chemistry pdf |
65 | 6 | 0.05 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
66 | 5 | 0.04 | http://www.tjpr.org/vol13_no8/2014_13_8_... |
67 | 5 | 0.04 | hepatitis awareness among students |
68 | 5 | 0.04 | components of tel fair is occidentalis?q... |
69 | 5 | 0.04 | new advances in antiprotozoal treatment |
70 | 5 | 0.04 | test for quinones (phytochemical screeni... |
71 | 5 | 0.04 | formulation and evaluation of gelatin mi... |
72 | 5 | 0.04 | polygonum convolvulus and resveratrol |
73 | 5 | 0.04 | suitable acid to dissolve chitosan |
74 | 5 | 0.04 | prevalence of hbs and hcv in euthyroid p... |
75 | 5 | 0.04 | piper crocatum |
76 | 5 | 0.04 | nifedipine magnetic microsphere |
77 | 5 | 0.04 | http://www.tjpr.org/jmanager/manuscript/... |
78 | 5 | 0.04 | nanoparticles + review |
79 | 5 | 0.04 | name herbs that use to analgesic/pdf |
80 | 5 | 0.04 | site:http://www.tjpr.org/jmanager/ |
81 | 5 | 0.04 | antioxidant piper crocatum |
82 | 5 | 0.04 | http://www.tjpr.org/vol13_no7/2014_13_7_... |
83 | 5 | 0.04 | definition of validation in pharmaceutic... |
84 | 5 | 0.04 | preparation of microsphere |
85 | 5 | 0.04 | penetration |
86 | 5 | 0.04 | applications of gold nanoparticles pdf |
87 | 5 | 0.04 | what is validation in pharma |
88 | 5 | 0.04 | cache:http://www.tjpr.org/vol10_no4/2011... |
89 | 4 | 0.03 | formulation and evaluation of metformin ... |
90 | 4 | 0.03 | perodental strips pdf review |
91 | 4 | 0.03 | index of synergism in olisd method + pro... |
92 | 4 | 0.03 | polymeric micells pdf file |
93 | 4 | 0.03 | l asparaginase pdf |
94 | 4 | 0.03 | oro dispercible tablet pdf?q=oro disperc... |
95 | 4 | 0.03 | mechanism of drug release from multipart... |
96 | 4 | 0.03 | hypercholesterolemia ; leaf extraction;... |
97 | 4 | 0.03 | tea+pdf |
98 | 4 | 0.03 | &si=cmsn7jay_8ecfu4qjgod-zsasa |
99 | 4 | 0.03 | http://www.tjpr.org/vol7_no2/729odeku.pd... |
100 | 4 | 0.03 | modifikasi mannitol |
101 | 4 | 0.03 | adverse drug interaction |
102 | 4 | 0.03 | what are the procedure for sample collec... |
103 | 4 | 0.03 | objective on control drug delievery syst... |
104 | 4 | 0.03 | www.ajol.info/index.php/tjpr/article/dow... |
105 | 4 | 0.03 | gold nanoparticle preparation,properties... |
106 | 4 | 0.03 | glipizide microspheres |
107 | 4 | 0.03 | physical and chemical properties of micr... |
108 | 4 | 0.03 | health benefits of tea pdf |
109 | 4 | 0.03 | use of nanoparticles in brain targeting ... |
110 | 4 | 0.03 | thiamine pyrophosphate (tpp) and pcd |
111 | 4 | 0.03 | traditional treatment for snake bite in ... |
112 | 4 | 0.03 | is it possible to get a pharmaceutical s... |
113 | 4 | 0.03 | pharmaceutical care pdf |
114 | 4 | 0.03 | about tea for pdf |
115 | 4 | 0.03 | synthesis and chemistry of anti cancer d... |
116 | 4 | 0.03 | manuscript manager |
117 | 4 | 0.03 | sublingual tablet review article |
118 | 4 | 0.03 | penetration enhancer |
119 | 4 | 0.03 | http://www.tjpr.org/vol10_no2/2011_10_2_... |
120 | 4 | 0.03 | formulation desire for short half life o... |
121 | 4 | 0.03 | a review articals on new techniques in d... |
122 | 4 | 0.03 | drugs purchasing pattern in developing c... |
123 | 4 | 0.03 | validation in pharmacy |
124 | 4 | 0.03 | cyclodextrin inclusion complex pdf |
125 | 4 | 0.03 | cortical layers nissl staining |
126 | 4 | 0.03 | &si=speedneto |
127 | 4 | 0.03 | validation in pharmaceuticals |
128 | 4 | 0.03 | muhammad iqbal et al., (2009) reported t... |
129 | 3 | 0.02 | routine operation phase in validation pr... |
130 | 3 | 0.02 | formulation and evaluation of microspon... |
131 | 3 | 0.02 | film coating review articles pdf |
132 | 3 | 0.02 | controlled release multiparticulates |
133 | 3 | 0.02 | nanoparticles review |
134 | 3 | 0.02 | http://www.tjpr.org/vol2_no2/22editorial... |
135 | 3 | 0.02 | filetype:pdf importance of medicinal pla... |
136 | 3 | 0.02 | explain artemisinin-based combination th... |
137 | 3 | 0.02 | antidiabetic activity of gloriosa superb... |
138 | 3 | 0.02 | &si=cnl2j6vawmecfupltaodlfka2a |
139 | 3 | 0.02 | mechanism of drug penetration in pharmac... |
140 | 3 | 0.02 | article review about range .pdf file dow... |
141 | 3 | 0.02 | malaria parasite vaccine development and... |
142 | 3 | 0.02 | conclusion of callus culture |
143 | 3 | 0.02 | advantages of micro particles |
144 | 3 | 0.02 | pharma validation?q=pharma validation |
145 | 3 | 0.02 | orodispersable tablet formulation |
146 | 3 | 0.02 | nanoparticals pdf |
147 | 3 | 0.02 | what is the state of pharmacy practice r... |
148 | 3 | 0.02 | pharmaceutical nanotechnology pdf |
149 | 3 | 0.02 | pdf of solid dispersion |
150 | 3 | 0.02 | erigeron floribundus |
151 | 3 | 0.02 | jurnal gastroretentive antasida |
152 | 3 | 0.02 | antidiarrheal activity of medicinal plan... |
153 | 3 | 0.02 | &si=maps4pc |
154 | 3 | 0.02 | neuroprotective |
155 | 3 | 0.02 | herbal medicine pdf |
156 | 3 | 0.02 | osmotic pump optimization |
157 | 3 | 0.02 | mucilages elasticity |
158 | 3 | 0.02 | method of nano particle in pdf file |
159 | 3 | 0.02 | handbook of medical laboratory science n... |
160 | 3 | 0.02 | 46aedf5250d6141583d0d6ac4245089d |
161 | 3 | 0.02 | podophyllum hexandrum invitro propagatio... |
162 | 3 | 0.02 | effect of zetapotential in drug delivery |
163 | 3 | 0.02 | loratadine |
164 | 3 | 0.02 | ipqa activities in pharma pdf |
165 | 3 | 0.02 | validation in pharmaceutical |
166 | 3 | 0.02 | new journal of pharmaceutics pdf file |
167 | 3 | 0.02 | effects of partition to penetration of d... |
168 | 3 | 0.02 | new reviw of thinflim tablet?q=new reviw... |
169 | 3 | 0.02 | filetype:pdf importance of medicinal pla... |
170 | 3 | 0.02 | tb clinical features complucations treat... |
171 | 3 | 0.02 | indian study on assess the knowledge of ... |
172 | 3 | 0.02 | drug delivery nanotechnology application... |
173 | 3 | 0.02 | nanoparticle review pdf |
174 | 3 | 0.02 | antibacterial activities of cida acuta o |
175 | 3 | 0.02 | tropical journal of pharmaceutical resea... |
176 | 3 | 0.02 | ruote of drugs administration mechanism ... |
177 | 3 | 0.02 | http://www.tjpr.org/vol13_no10/2014_13_1... |
178 | 3 | 0.02 | http:/www.tjpr.org |
179 | 3 | 0.02 | how to prepare concentrations of extract... |
180 | 3 | 0.02 | control drug delivery system |
181 | 3 | 0.02 | 1596-5996 |
182 | 3 | 0.02 | pharmaceutical importance of electron af... |
183 | 3 | 0.02 | validation of "reagents" in pharmaceutic... |
184 | 3 | 0.02 | pdf of introduction of nano particles |
185 | 3 | 0.02 | normal disintigeration time for buccal t... |
186 | 3 | 0.02 | what is validation for pharmaceutical |
187 | 3 | 0.02 | microsponges research articles |
188 | 3 | 0.02 | http://www.tjpr.org/vol13_no10/2014_13_1... |
189 | 3 | 0.02 | aspect of microbial quality of some milk... |
190 | 3 | 0.02 | nanoparticles reviews |
191 | 3 | 0.02 | pdf on tablet formation?q=pdf on tablet ... |
192 | 3 | 0.02 | ofokansi, chloroquine charge transfer |
193 | 3 | 0.02 | suppositories pdf |
194 | 3 | 0.02 | wound healing property |
195 | 3 | 0.02 | levels of antioxidant parameters ln alb... |
196 | 3 | 0.02 | actinomycetes enzyme |
197 | 3 | 0.02 | ppt of formulation and evaluation of sol... |
198 | 3 | 0.02 | pharmaceutical validation pdf |
199 | 3 | 0.02 | pharmaceutical care pdf journal |
200 | 3 | 0.02 | &ptb=aa4f53fd-e2e7-49ce-982a-ce43e827577... |
201 | 3 | 0.02 | role of pharmacist in hospital |
202 | 3 | 0.02 | http://www.tjpr.org/vol7_no2/7210pachuau... |
203 | 3 | 0.02 | in process control pharmaceutical |
204 | 3 | 0.02 | evaluation of anti microbial pdf |
205 | 3 | 0.02 | toothpaste formulation |
206 | 3 | 0.02 | clinical signs of brucellosis in humans |
207 | 3 | 0.02 | mohanraj, vj dan chen y. nanoparticles- ... |
208 | 3 | 0.02 | brucellosis treatment+table |
209 | 3 | 0.02 | wound healing activity of plant extract?... |
210 | 3 | 0.02 | benifit of tea for pdf |
211 | 3 | 0.02 | pdf reducing patients waiting time for e... |
212 | 3 | 0.02 | common enzymes in actinomycetes |
213 | 3 | 0.02 | effect of diet containing seed oftelfai... |
214 | 3 | 0.02 | preparation of proniosomal gel |
215 | 3 | 0.02 | five abstracts related to the efficacy o... |
216 | 3 | 0.02 | adverse effect of drugs for treating mal... |
217 | 2 | 0.02 | validation pharmaceutical |
218 | 2 | 0.02 | validation of pharmaceuticals process wi... |
219 | 2 | 0.02 | responsibility of pharmacist in assuranc... |
220 | 2 | 0.02 | gastroretentive freez dried matrices pdf |
221 | 2 | 0.02 | detailed procedure of inprocess to finis... |
222 | 2 | 0.02 | dentifrice formulation pdf |
223 | 2 | 0.02 | complication pdf file download |
224 | 2 | 0.02 | control of raw material in pharma |
225 | 2 | 0.02 | challenges of traditional medicine |
226 | 2 | 0.02 | singh j orodispersible tablet of meloxic... |
227 | 2 | 0.02 | mcc guideline for process validation |
228 | 2 | 0.02 | validation pdf |
229 | 2 | 0.02 | preparation of sodium alginate nanoparti... |
230 | 2 | 0.02 | mode of action of beecham ampiclox |
231 | 2 | 0.02 | antiangiogenic effect of animal extracts |
232 | 2 | 0.02 | method development andvalidation of lumi... |
233 | 2 | 0.02 | simple distillation (practical textbook ... |
234 | 2 | 0.02 | pharmaceutical process validation |
235 | 2 | 0.02 | cinnamon and mda |
236 | 2 | 0.02 | andries f marais., mingna song., melgard... |
237 | 2 | 0.02 | what is pharmaceutical process validatio... |
238 | 2 | 0.02 | reserpine pdf |
239 | 2 | 0.02 | transdermal permeation enhancer |
240 | 2 | 0.02 | extraction method for fresh plant pdf |
241 | 2 | 0.02 | hardness required in slugging |
242 | 2 | 0.02 | fast disintegrating tablets pdf |
243 | 2 | 0.02 | chemical enhancer |
244 | 2 | 0.02 | a number of subjective and objective fea... |
245 | 2 | 0.02 | system suitability in hplc pdf |
246 | 2 | 0.02 | importance of doing both c3 , c4 level |
247 | 2 | 0.02 | microbiology milk in nigeria |
248 | 2 | 0.02 | formulation of tablet pdf?q=formulation ... |
249 | 2 | 0.02 | effect of alstonia boonei pdf |
250 | 2 | 0.02 | efficacy of herbal products in reducing ... |
251 | 2 | 0.02 | validations in pharmaceutical manufactur... |
252 | 2 | 0.02 | nri absorption gold nano stacture and it... |
253 | 2 | 0.02 | http://www.tjpr.org/vol8_no1/2009_8_1_9.... |
254 | 2 | 0.02 | hepatoprotective activity pdf |
255 | 2 | 0.02 | what are the methods of pharmaceutical a... |
256 | 2 | 0.02 | pharmaceutical products and packaging ma... |
257 | 2 | 0.02 | nanoparticales a review |
258 | 2 | 0.02 | how many venomous snakes are in nigeria |
259 | 2 | 0.02 | comlexation techniques pdf |
260 | 2 | 0.02 | benifits qualities of tea in pdf file |
261 | 2 | 0.02 | artificial neural networks evaluation in... |
262 | 2 | 0.02 | research articles on dissolution study o... |
263 | 2 | 0.02 | prodrug of fenoprofen pdf |
264 | 2 | 0.02 | penetration enhancers |
265 | 2 | 0.02 | isolation and characterization of bioact... |
266 | 2 | 0.02 | download of delivary part |
267 | 2 | 0.02 | development validation of process & equi... |
268 | 2 | 0.02 | system suitability in hplc routine word |
269 | 2 | 0.02 | pharma validation defination |
270 | 2 | 0.02 | nano partical drug delivry system |
271 | 2 | 0.02 | http://www.tjpr.org/vol6_no3/631editoria... |
272 | 2 | 0.02 | &si=cjkkeqjw8ysdbrchhpxjvpvmztabeiqakn89... |
273 | 2 | 0.02 | simulation validation prtocol pharma |
274 | 2 | 0.02 | malnutrition amongst under-five years |
275 | 2 | 0.02 | determination simultaneous of concentrat... |
276 | 2 | 0.02 | antituberculin research pdf download |
277 | 2 | 0.02 | wound healing by which mineral selenium?... |
278 | 2 | 0.02 | objectives of quality control techniques... |
279 | 2 | 0.02 | penetration enhancer |
280 | 2 | 0.02 | international journal review of nanopart... |
281 | 2 | 0.02 | international journal of nanomedicine 20... |
282 | 2 | 0.02 | flavonoids in treatment of microorganis... |
283 | 2 | 0.02 | effects of high relative humidity on com... |
284 | 2 | 0.02 | evaluation of hepatoprotective activity |
285 | 2 | 0.02 | dioscorea dumetorum |
286 | 2 | 0.02 | how can pharmacist in academic setting p... |
287 | 2 | 0.02 | antioxidant effect of ichnocarpus frutes... |
288 | 2 | 0.02 | pharmaceutical equipment validation |
289 | 2 | 0.02 | pdf file for evaluation of paracetamol?q... |
290 | 2 | 0.02 | hplc precision accuracy.pdf |
291 | 2 | 0.02 | brands name of all tablets and uses pdf ... |
292 | 2 | 0.02 | anti fungal activity of trichophyton men... |
293 | 2 | 0.02 | pharmacy validation process |
294 | 2 | 0.02 | process control issues in validation |
295 | 2 | 0.02 | isolation of mefmanuc acid from ponston |
296 | 2 | 0.02 | isolation and identification of enteric ... |
297 | 2 | 0.02 | hydroxypropyl methylcellulose solvent |
298 | 2 | 0.02 | hayat mayson |
299 | 2 | 0.02 | candy and bitter kola interaction |
300 | 2 | 0.02 | review on multiparticulate system.pdf |
301 | 2 | 0.02 | pdf"method+stevia" |
302 | 2 | 0.02 | patient satisfaction with clinics in nig... |
303 | 2 | 0.02 | which plant shows antidirrgeal activity |
304 | 2 | 0.02 | what chemicals help skin penetration |
305 | 2 | 0.02 | nisoldipine stability indicating methods |
306 | 2 | 0.02 | kokate c.k "practical ppharmacognosy val... |
307 | 2 | 0.02 | how to apply quality by design on contro... |
308 | 2 | 0.02 | copc sample on hypertension pp |
309 | 2 | 0.02 | what do you mean by validation in farmac... |
310 | 2 | 0.02 | newbouldia laevis(ex beauv) seem with an... |
311 | 2 | 0.02 | beta sitosterol-o-glucoside nmr,pdf |
312 | 2 | 0.02 | role of ethnobotany in modern day world |
313 | 2 | 0.02 | prodrug of flurbiprofen pdf |
314 | 2 | 0.02 | block copolymer application |
315 | 2 | 0.02 | bitter kola plant diagram |
316 | 2 | 0.02 | article on development of immediate rele... |
317 | 2 | 0.02 | www.pharma product ion validations downl... |
318 | 2 | 0.02 | pharmaceutical products of microbilogica... |
319 | 2 | 0.02 | download all journals done on p.beauvsee... |
320 | 2 | 0.02 | computer in pharmacy, optimization techn... |
321 | 2 | 0.02 | atorvastatin nano |
322 | 2 | 0.02 | topical spray formulations.pdf |
323 | 2 | 0.02 | pharma validation |
324 | 2 | 0.02 | gc-ms analysis for essential compounds o... |
325 | 2 | 0.02 | types of validation pdf |
326 | 2 | 0.02 | review article on oraly disintragrating ... |
327 | 2 | 0.02 | download research articles on preparatio... |
328 | 2 | 0.02 | algın yapar, Özge İnal, yal... |
329 | 2 | 0.02 | www.tjpr.org |
330 | 2 | 0.02 | pdf on ointment and thier preparations |
331 | 2 | 0.02 | nanoparticle uptake by the oral route |
332 | 2 | 0.02 | http://www.tjpr.org/vol13_no10/2014_13_1... |
333 | 2 | 0.02 | nanoparticle pdf |
334 | 2 | 0.02 | formulation of microsphere |
335 | 2 | 0.02 | formulatin and evaluation of orodispersa... |
336 | 2 | 0.02 | pdf evalutions of tooth paste |
337 | 2 | 0.02 | low complement c3 normal c4 |
338 | 2 | 0.02 | ipqa process in pharmacy |
339 | 2 | 0.02 | formulation. of microsphere |
340 | 2 | 0.02 | 2 |
341 | 2 | 0.02 | synthesis of gold nanoparticles review |
342 | 2 | 0.02 | hiv-1 gp120 and molecular dynamics |
343 | 2 | 0.02 | antipyretic activity of plant extracts a... |
344 | 2 | 0.02 | www.amfanin rai rai |
345 | 2 | 0.02 | validation process in pharma |
346 | 2 | 0.02 | niosomes of isoniazid |
347 | 2 | 0.02 | journal colouring gram.pdf |
348 | 2 | 0.02 | cassia occidentalis |
349 | 2 | 0.02 | metronidazole pdf |
350 | 2 | 0.02 | list and explain the challenges of tradi... |
351 | 2 | 0.02 | disc diffusion assay for calculation of ... |
352 | 2 | 0.02 | pharmaceutical products formed from micr... |
353 | 2 | 0.02 | pdf hepatoprotective activity by histopa... |
354 | 2 | 0.02 | microbial load in milk and milk product |
355 | 2 | 0.02 | early lupus, c3 c4 levels |
356 | 2 | 0.02 | boerhavia diffusa root extract |
357 | 2 | 0.02 | solvent to dissolve glipiziide |
358 | 2 | 0.02 | pdf file on papaya effect on diabetes |
359 | 2 | 0.02 | explain surface area of nanoparticles de... |
360 | 2 | 0.02 | isolation of microbial quality of milk |
361 | 2 | 0.02 | cyclodextrin pdf |
362 | 2 | 0.02 | all pharma instrument calibration sops |
363 | 2 | 0.02 | validation of equipments in pharmacy |
364 | 2 | 0.02 | plants with antidiarrheal activities |
365 | 2 | 0.02 | herbal toothpaste formulation review ary... |
366 | 2 | 0.02 | evalution of hepato protective activity?... |
367 | 2 | 0.02 | challenges with malaria vaccine developm... |
368 | 2 | 0.02 | pdf method of extraction of garcinia kol... |
369 | 2 | 0.02 | antimicrobial activities of sida acuta l... |
370 | 2 | 0.02 | physicochemical characteristics of a pro... |
371 | 2 | 0.02 | pharma validations pdf |
372 | 2 | 0.02 | formulation & evaluation of the furosemi... |
373 | 2 | 0.02 | comparative study between foreign and ni... |
374 | 2 | 0.02 | validation in pharmaceutical pdf downloa... |
375 | 2 | 0.02 | tableting deformation sem?q=tableting de... |
376 | 2 | 0.02 | "peptide library" |
377 | 2 | 0.02 | serum c3 c4 |
378 | 2 | 0.02 | pharmaceutical products formed from micr... |
379 | 2 | 0.02 | composition of various ointments.pdf |
380 | 2 | 0.02 | antimicrobial activity test pdf |
381 | 2 | 0.02 | toothpaste composition pdf |
382 | 2 | 0.02 | research papar on development of immedia... |
383 | 2 | 0.02 | pdf file on papaya effect on diabetes in... |
384 | 2 | 0.02 | http://www.tjpr.org/vol13_no10/2014_13_1... |
385 | 2 | 0.02 | different phase of process validation |
386 | 2 | 0.02 | testing of agglomerates pdf |
387 | 2 | 0.02 | antimicrobial activity of bitter cola pd... |
388 | 2 | 0.02 | validation in pharmaceutical industry pd... |
389 | 2 | 0.02 | oroki as a sex enhancer |
390 | 2 | 0.02 | sohel.rana.situ |
391 | 2 | 0.02 | effect of canarium schweinfurthii to ma... |
392 | 2 | 0.02 | alstonia boonei pdf |
393 | 2 | 0.02 | microsphere preparation pdf |
394 | 2 | 0.02 | validation in pharmaceutical pdf |
395 | 2 | 0.02 | nanopartical drug delivery system |
396 | 2 | 0.02 | microbial spoilage and preservation of p... |
397 | 2 | 0.02 | five abstracts related to the efficacy o... |
398 | 2 | 0.02 | disentegrating tablets |
399 | 2 | 0.02 | process control issues in pharmaceutical... |
400 | 2 | 0.02 | pharmaceutical equipments validation |
401 | 2 | 0.02 | journal giving fruit pepeya in diabetic ... |
402 | 2 | 0.02 | formulation of dentifrices in pdf |
403 | 2 | 0.02 | all journals on p.beauvseeman exbureau?q... |
404 | 2 | 0.02 | what is in process testing pharmaceutics |
405 | 2 | 0.02 | signs &symptoms of brucellosis pdf |
406 | 2 | 0.02 | phytochemical test procedures pdf |
407 | 2 | 0.02 | journal of pharm. urine as antimicrobial |
408 | 2 | 0.02 | advantages of using gas chromaotography ... |
409 | 2 | 0.02 | oral dispersing tablets |
410 | 2 | 0.02 | erigeron |
411 | 2 | 0.02 | what are the nutrients present in sida a... |
412 | 2 | 0.02 | sp tablets |
413 | 2 | 0.02 | preparation and evaluation of microspher... |
414 | 2 | 0.02 | patients knowledge on diabetes mellitus ... |
415 | 2 | 0.02 | comparative antimicrobial activity of so... |
416 | 2 | 0.02 | colorimetric determinations of different... |
417 | 2 | 0.02 | brucellosis treatment after complication... |
418 | 2 | 0.02 | ac3e5c6a9b423210e7c1dfdf9d8c91ce |
419 | 2 | 0.02 | pharmacygateway nanotechnology in drug d... |
420 | 2 | 0.02 | tropical dosage form pdf |
421 | 2 | 0.02 | melting point of paracetsmol pdf granula... |
422 | 2 | 0.02 | low c3 and c4 differential diagnosis |
423 | 2 | 0.02 | http://www.tjpr.org/vol13_no10/2014_13_1... |
424 | 2 | 0.02 | download all analysis done on newboulda ... |
425 | 2 | 0.02 | renal disease with low c3 and c4 level? |
426 | 2 | 0.02 | http://www.tjpr.org/vol7_no1/719onanuga.... |
427 | 2 | 0.02 | http/:/www.tjpr.org |
428 | 2 | 0.02 | good dispensing practice pdf |
429 | 2 | 0.02 | antimicrobial activity of plant extracts... |
430 | 2 | 0.02 | antidiarrheal herbal plants |
431 | 2 | 0.02 | boerhavia diffusa in weight loss |
432 | 2 | 0.02 | drug delivery pdf |
433 | 2 | 0.02 | al_groom @hotmail.com |
434 | 2 | 0.02 | research on antimicrobial research using... |
435 | 2 | 0.02 | http://www.tjpr.org/jmanager/manuscript/... |
436 | 2 | 0.02 | detail and whole pharma guidline related... |
437 | 2 | 0.02 | tropical journal of pharmaceutical resea... |
438 | 2 | 0.02 | olaniyi and ogungbamila pharmaceutical t... |
439 | 2 | 0.02 | any,contains,health benefits of tea |
440 | 2 | 0.02 | &cat=204 |
441 | 2 | 0.02 | depression among students |
442 | 2 | 0.02 | stability using hplc |
443 | 2 | 0.02 | preparation and evaluayion of orodispers... |
444 | 2 | 0.02 | http://www.tjpr.org/vol6_no1/614sangeeth... |
445 | 2 | 0.02 | evaluation of antihypertensive polyherba... |
446 | 2 | 0.02 | what is green chemistry in nigeria |
447 | 2 | 0.02 | stability indicating method?q=stability ... |
448 | 2 | 0.02 | reserch paper on stabiity indicating hpl... |
449 | 2 | 0.02 | permiation enhancers |
450 | 2 | 0.02 | odt tablet glimipyride on research pdf?q... |
451 | 2 | 0.02 | isolation and characterization of bioact... |
452 | 2 | 0.02 | toad poison in nigeria |
453 | 2 | 0.02 | rahela ambaras khan |
454 | 2 | 0.02 | pharmacuetical validation pdf |
455 | 2 | 0.02 | pdf on tea |
456 | 2 | 0.02 | formulation ofcparacetamol microspheres |
457 | 2 | 0.02 | drug delivery and nature relation pdf |
458 | 2 | 0.02 | bionanotechnology books pdf |
459 | 2 | 0.02 | application of nano particles in catalys... |
460 | 2 | 0.02 | history of pharmacy technician practice... |
461 | 2 | 0.02 | propyphenazone advantages - disadvantage... |
462 | 2 | 0.02 | prep and evaluation of microspheres |
463 | 2 | 0.02 | pharma process validation?q=pharma proce... |
464 | 2 | 0.02 | efficacy of ivermectin against strongylo... |
465 | 2 | 0.02 | ,hkang@dankook.ac.kr |
466 | 2 | 0.02 | protocol for design and evaluation for a... |
467 | 2 | 0.02 | journal about smoking in penang |
468 | 2 | 0.02 | eurycoma longifolia |
469 | 2 | 0.02 | properties of microcrystaline celloluse(... |
470 | 2 | 0.02 | procedure for hrdness,friability,drug co... |
471 | 2 | 0.02 | assay of chloroquine phosphate ebook |
472 | 2 | 0.02 | serum c3 |
473 | 2 | 0.02 | dose required to study antioxidants acti... |
474 | 2 | 0.02 | objective of ethnobotany |
475 | 2 | 0.02 | brucellosis treatment regime |
476 | 2 | 0.02 | biodegradable poly(d,l-lactic-co-glycoli... |
477 | 2 | 0.02 | antimicrobialsdownloadinpdffile |
478 | 2 | 0.02 | tropical journal of pharmacy |
479 | 2 | 0.02 | hepatoprotective ccl4 inducer procedure ... |
480 | 2 | 0.02 | asparaginase enzyme pdf |
481 | 2 | 0.02 | 50040111 |
482 | 2 | 0.02 | role of hospital pharmacy for varius hos... |
483 | 2 | 0.02 | quality control and pharmaceutical proce... |
484 | 2 | 0.02 | pharmaceutical equipments pdf |
485 | 2 | 0.02 | validation definition pharmaceutical |
486 | 2 | 0.02 | antidiarrhea plants |
487 | 2 | 0.02 | z a suleiman and j. muazu |
488 | 2 | 0.02 | pharma validation protocol |
489 | 2 | 0.02 | gastroretentive swelling pdf |
490 | 2 | 0.02 | review of nano particles |
491 | 2 | 0.02 | pharmaceutical research |
492 | 2 | 0.02 | jaysukh j hirani, dhaval a rathod, kanti... |
493 | 2 | 0.02 | antidiarrheal activity pdf |
494 | 2 | 0.02 | stability indicating method itd |
495 | 2 | 0.02 | solid dispersion pdf file |
496 | 2 | 0.02 | nigeria herbal research on leaf extarct ... |
497 | 2 | 0.02 | medicine outer layering by starch |
498 | 2 | 0.02 | validation of process&equipment |
499 | 2 | 0.02 | stevia antifungal |
500 | 2 | 0.02 | pharmaceutical process validation |
501 | 2 | 0.02 | chemical enhancers transdermal delivery |
502 | 2 | 0.02 | adsorbtion property of kaolin |
503 | 2 | 0.02 | validation of pharmaceutical processes p... |
504 | 2 | 0.02 | protocol for isolation of nutrients by l... |
505 | 2 | 0.02 | pharmacy perception penang |
506 | 2 | 0.02 | microsphere of gelatin |
507 | 2 | 0.02 | how to solve the problum if friability o... |
508 | 2 | 0.02 | green tea pdf |
509 | 2 | 0.02 | pdf health benefits of tea |
510 | 2 | 0.02 | nanoparticles are defined as particulate... |
511 | 2 | 0.02 | difference b/w controlled,sustained,puls... |
512 | 2 | 0.02 | process validation in pharmaceuticals |
513 | 2 | 0.02 | prescription pattern of antihypertensive... |
514 | 2 | 0.02 | nanoparticles in drug delivery pdf |
515 | 2 | 0.02 | composition of telfairia occidentalis ac... |
516 | 2 | 0.02 | any,contains,benefits of tea |
517 | 1 | 0.01 | various application of green synthesized... |
518 | 1 | 0.01 | s.k jain dr hari singh gour university p... |
519 | 1 | 0.01 | microsoft document on drug stock-out com... |
520 | 1 | 0.01 | how to prepare cc standards of naproxen |
521 | 1 | 0.01 | inclusion coplexation with beta cyclodex... |
522 | 1 | 0.01 | preparation of niosomes hydrophilic dr... |
523 | 1 | 0.01 | normal value of c3 |
524 | 1 | 0.01 | biological penetration enhancer with pro... |
525 | 1 | 0.01 | anticholinesterase invitro assays |
526 | 1 | 0.01 | journal dentification of chloramphenicol... |
527 | 1 | 0.01 | http://www.tjpr.org/vol10_no3/index.php |
528 | 1 | 0.01 | gastroretentive |
529 | 1 | 0.01 | filetype:pdf cross sectional study on ns... |
530 | 1 | 0.01 | hidrogel hplc |
531 | 1 | 0.01 | bisphenol a saudi arabia |
532 | 1 | 0.01 | bsa use in formation of gold nanoparticl... |
533 | 1 | 0.01 | controlled dermal delievey of lipophili ... |
534 | 1 | 0.01 | clinical investigation of treatment fail... |
535 | 1 | 0.01 | cyp2d6 mutation and t107i amino acid |
536 | 1 | 0.01 | popularity of herbal drugs as haematini... |
537 | 1 | 0.01 | plant extracts against esbls |
538 | 1 | 0.01 | mail lobeline.com |
539 | 1 | 0.01 | modern uses of plant swietenia |
540 | 1 | 0.01 | types of validation in pharma |
541 | 1 | 0.01 | singhô€€ƒ rp.ô€€ƒ recentô€€ƒ approachô€€... |
542 | 1 | 0.01 | validation batches pharmaceuticals |
543 | 1 | 0.01 | penetration enhancer example |
544 | 1 | 0.01 | official tests for orally disintegrating... |
545 | 1 | 0.01 | nanogold pyrrolidone mushroom polysaccha... |
546 | 1 | 0.01 | a tropical journal |
547 | 1 | 0.01 | chitosan as polymer in drug delivery pdf |
548 | 1 | 0.01 | estimation of microflora of milk of meth... |
549 | 1 | 0.01 | equipments for emulsion preparation pdf |
550 | 1 | 0.01 | permeation enhancers for transdermal dru... |
551 | 1 | 0.01 | monitoring patient waiting times |
552 | 1 | 0.01 | process development in validation |
553 | 1 | 0.01 | research about pharmaceutical preparatio... |
554 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
555 | 1 | 0.01 | the use of local starches as pharmaceuti... |
556 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
557 | 1 | 0.01 | jurnal tentang lactoferrin |
558 | 1 | 0.01 | inluence of differnt grade of hpmc in dr... |
559 | 1 | 0.01 | how pharmacy practice started in nigeria |
560 | 1 | 0.01 | solid dispersions pdf |
561 | 1 | 0.01 | review small size gold nano?q=review sma... |
562 | 1 | 0.01 | podophyllum hexandrum invitro propagatio... |
563 | 1 | 0.01 | nurul jannah ambak |
564 | 1 | 0.01 | orodipersible tab review article |
565 | 1 | 0.01 | what should be outcomes of cleaning val... |
566 | 1 | 0.01 | snake bites in nigeria |
567 | 1 | 0.01 | acrylic pressure sensitive adhesive matr... |
568 | 1 | 0.01 | antidiarrheal activity of plants |
569 | 1 | 0.01 | gold nanoparticles drug?q=gold nanoparti... |
570 | 1 | 0.01 | &ptb=56b985f4-2b35-4cc3-9081-dbfa17c75d9... |
571 | 1 | 0.01 | what causes a low c 4 |
572 | 1 | 0.01 | biochemistry behind the health benefits ... |
573 | 1 | 0.01 | &ptb=9cc323eb-4203-4314-99fe-c82d15415f1... |
574 | 1 | 0.01 | crushing strength-friability ratio |
575 | 1 | 0.01 | http://www.tjpr.org/vol13_no10/2014_13_1... |
576 | 1 | 0.01 | formulation for a herbal toothpaste |
577 | 1 | 0.01 | articles about patients waiting |
578 | 1 | 0.01 | author:"lessoy t. zoué" |
579 | 1 | 0.01 | jurnal gastroretentive untuk antacids |
580 | 1 | 0.01 | permeability enhancer |
581 | 1 | 0.01 | journal of universiti malaysia pahang |
582 | 1 | 0.01 | gastroretentive drug delivery buoyancy o... |
583 | 1 | 0.01 | review articles on effervescent tablets ... |
584 | 1 | 0.01 | requirement to make nanoparticles |
585 | 1 | 0.01 | tramadol controlled release drug deliver... |
586 | 1 | 0.01 | skin cosmetics theory pdf pharmacy |
587 | 1 | 0.01 | preparation of gold nanoparticles |
588 | 1 | 0.01 | product development canvas for pharma fi... |
589 | 1 | 0.01 | phenylhydrazine and chitosan reactions |
590 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
591 | 1 | 0.01 | spectophotometric analysis of drug by ex... |
592 | 1 | 0.01 | stability indicating method cynatine hns... |
593 | 1 | 0.01 | about tea details pdf file?q=about tea d... |
594 | 1 | 0.01 | download journal international about sta... |
595 | 1 | 0.01 | compression defect of paracetamol tablet... |
596 | 1 | 0.01 | ‎vinodh rajangam |
597 | 1 | 0.01 | pharmaceutical care in nigeria |
598 | 1 | 0.01 | boerhaavia diffusa |
599 | 1 | 0.01 | chitosan low molecular weight |
600 | 1 | 0.01 | skin permeation enhancers in trans derma... |
601 | 1 | 0.01 | pdf gold chloride nanoparticle using gre... |
602 | 1 | 0.01 | properties of nanoparticles pdf |
603 | 1 | 0.01 | basheer 2010 microemulsion |
604 | 1 | 0.01 | assay for lipid peroxides in animal tiss... |
605 | 1 | 0.01 | primary healthcare and the pharmacist's ... |
606 | 1 | 0.01 | pharmaceutical application of nanopartic... |
607 | 1 | 0.01 | nanoparticles a review pdf |
608 | 1 | 0.01 | phc pharmacy policies |
609 | 1 | 0.01 | formulation of microsphere in 1950 |
610 | 1 | 0.01 | droperidol +nanoparticles+pharmacokineti... |
611 | 1 | 0.01 | http://www.tjpr.org/vol13_no10/2014_13_1... |
612 | 1 | 0.01 | metronidazole internal standard |
613 | 1 | 0.01 | chloramphenicol base in acetic acid per... |
614 | 1 | 0.01 | aspirin microcapsule |
615 | 1 | 0.01 | gc-ms analysis of avocado oil |
616 | 1 | 0.01 | influence of soft parrafin on the stabil... |
617 | 1 | 0.01 | gcm model for benin city nigeria |
618 | 1 | 0.01 | different sizes of aspirin capsules |
619 | 1 | 0.01 | alginate blended beads ionotropic gelati... |
620 | 1 | 0.01 | adherence to international guidelines in... |
621 | 1 | 0.01 | pharmaceutical research articles of oral... |
622 | 1 | 0.01 | what is main purpose of controlled poros... |
623 | 1 | 0.01 | transdermal delivery systems |
624 | 1 | 0.01 | why does c3 and c4 decrease |
625 | 1 | 0.01 | estimation of sgot in tissue homogenate ... |
626 | 1 | 0.01 | how many pharmaceutical company marketin... |
627 | 1 | 0.01 | chemical contents of picralima nitida le... |
628 | 1 | 0.01 | carbomer in antibacterial gels |
629 | 1 | 0.01 | dmso and caffeine skin treatment |
630 | 1 | 0.01 | microglia bv2 |
631 | 1 | 0.01 | http://www.tjpr.org/vol13_no10/2014_13_1... |
632 | 1 | 0.01 | nigerian journal of pharmacology |
633 | 1 | 0.01 | ointment pdf |
634 | 1 | 0.01 | pharmaceutical preparation of herbal dru... |
635 | 1 | 0.01 | herbal preparations pdf |
636 | 1 | 0.01 | histological effect of ethanolic extract... |
637 | 1 | 0.01 | tropical j of pharma research |
638 | 1 | 0.01 | urtica dioica induced cytotoxicity in hu... |
639 | 1 | 0.01 | stability indicating hplc method develop... |
640 | 1 | 0.01 | total serum complementคืภ|
641 | 1 | 0.01 | 80% displacment with suppositories |
642 | 1 | 0.01 | appu rathinavelu |
643 | 1 | 0.01 | pharmaceutical research |
644 | 1 | 0.01 | lupus test results low c3 serum |
645 | 1 | 0.01 | difference betweenchloroquine hydroclori... |
646 | 1 | 0.01 | chloroquine phosphate analysis |
647 | 1 | 0.01 | gentian violet as antileishmanial infect... |
648 | 1 | 0.01 | effect of aspirin on fractalkine in rats... |
649 | 1 | 0.01 | leuprolide release |
650 | 1 | 0.01 | nanotech approaches to drug delivery and... |
651 | 1 | 0.01 | nano particles pdf |
652 | 1 | 0.01 | nanoparticles—a review?q=nanoparticles... |
653 | 1 | 0.01 | method of nanoparticle in ofloxacin |
654 | 1 | 0.01 | malaria vaccines challengs and challenge... |
655 | 1 | 0.01 | nano particle in pdf |
656 | 1 | 0.01 | process validation programmewikki pedia |
657 | 1 | 0.01 | validation of pharma |
658 | 1 | 0.01 | amoxicillin tablets studies,pdf |
659 | 1 | 0.01 | acp8 |
660 | 1 | 0.01 | validation of drug |
661 | 1 | 0.01 | translate |
662 | 1 | 0.01 | journal of pharmacy research submission... |
663 | 1 | 0.01 | pleurotus tuber-regium |
664 | 1 | 0.01 | properties of tablet formed with maize s... |
665 | 1 | 0.01 | role of community pharmacist in family p... |
666 | 1 | 0.01 | c3 complement |
667 | 1 | 0.01 | artemisinin side effects |
668 | 1 | 0.01 | biodegradable nanoparticles of poly(lact... |
669 | 1 | 0.01 | anti cancer agent as metal ferrites |
670 | 1 | 0.01 | annexin curcumin |
671 | 1 | 0.01 | antiangiogenic effect of ficus deltoidea... |
672 | 1 | 0.01 | concentration of bougainvillea spectabil... |
673 | 1 | 0.01 | chuks pharmacy in benin |
674 | 1 | 0.01 | conclusion write up in process developme... |
675 | 1 | 0.01 | diabetes prevalence in malaysia |
676 | 1 | 0.01 | &searchfor=dispensing doctors in malaysi... |
677 | 1 | 0.01 | piper betle as anticandida pdf |
678 | 1 | 0.01 | role of pharmacist in present scenario |
679 | 1 | 0.01 | hyperlipidemia isoflavone mice |
680 | 1 | 0.01 | http://www.tjpr.org/vol13_no9/2014_13_9_... |
681 | 1 | 0.01 | mediafire pharmaceutical validation |
682 | 1 | 0.01 | normal value of serum glutamate oxalate ... |
683 | 1 | 0.01 | kohli, d. p. s; dan d. h. shah. 1998. dr... |
684 | 1 | 0.01 | journal anticancer gynura segetum ic50 |
685 | 1 | 0.01 | journal of cream pharmacy research |
686 | 1 | 0.01 | references on pharmacy waiting time |
687 | 1 | 0.01 | puchong |
688 | 1 | 0.01 | what is the meaning of the word monolith... |
689 | 1 | 0.01 | challenges in herbal drug development |
690 | 1 | 0.01 | alomo bitters dosage |
691 | 1 | 0.01 | advantage of pull system in drug supplie... |
692 | 1 | 0.01 | 2. dey ns, majumdar s, rao meb. multipa... |
693 | 1 | 0.01 | trop. j. pharm. res |
694 | 1 | 0.01 | abdulazeez, omole, and ojulari, 2014 |
695 | 1 | 0.01 | nanokapsul-mohanraj and chen 2006 |
696 | 1 | 0.01 | green synthesis of silver nano particles... |
697 | 1 | 0.01 | reseach on suppositries |
698 | 1 | 0.01 | polymeric micelles pdf |
699 | 1 | 0.01 | solid lipid nanoparticles: |
700 | 1 | 0.01 | cloxacillin and antimalaria do they inte... |
701 | 1 | 0.01 | development and optimization insulin |
702 | 1 | 0.01 | attributes of an ideal penetration enhen... |
703 | 1 | 0.01 | chemical equivalence generic |
704 | 1 | 0.01 | hypochlorous acid antimicrobial activity |
705 | 1 | 0.01 | immunology-complement c3 c4 deficiency |
706 | 1 | 0.01 | effect of total dissolved solids on alan... |
707 | 1 | 0.01 | chemical constituents isolated from thun... |
708 | 1 | 0.01 | review drugs delivery by nanoparticles |
709 | 1 | 0.01 | quality control of tetracycline capsules... |
710 | 1 | 0.01 | reseach must be accomponiedby pictures n... |
711 | 1 | 0.01 | application of gold nanoparticles |
712 | 1 | 0.01 | au nanoparticles drug delivery in biolo... |
713 | 1 | 0.01 | approved diagnosis for c3 and c4 labs |
714 | 1 | 0.01 | antimicrobial activity of plant extracts... |
715 | 1 | 0.01 | 13699478376 |
716 | 1 | 0.01 | formulations with tramadol |
717 | 1 | 0.01 | entrepreneurship development for pharmac... |
718 | 1 | 0.01 | nanotechnology pdf |
719 | 1 | 0.01 | orally disintegrating tablets and sublin... |
720 | 1 | 0.01 | drugs of choice to prepare disentegratin... |
721 | 1 | 0.01 | articles on dissolution of herbal produc... |
722 | 1 | 0.01 | what causes c3 complement level to dip? |
723 | 1 | 0.01 | problems in developement of vaccine agai... |
724 | 1 | 0.01 | preparation of nanosuspension of esomepr... |
725 | 1 | 0.01 | role of hypercholesterolemia and diabete... |
726 | 1 | 0.01 | tropical journal of pharma research |
727 | 1 | 0.01 | nano tecnology a new boon for medicines ... |
728 | 1 | 0.01 | mail wooshin-gi.com |
729 | 1 | 0.01 | introduction of microsphere from paracet... |
730 | 1 | 0.01 | euchrestaflavanone a |
731 | 1 | 0.01 | recent approach in clinical and experime... |
732 | 1 | 0.01 | reliable sources for different toothpast... |
733 | 1 | 0.01 | report pharmaceutical drug production co... |
734 | 1 | 0.01 | yustina sri hartini |
735 | 1 | 0.01 | triterpene petroleum ether 50ml |
736 | 1 | 0.01 | lipid nanoparticle solid |
737 | 1 | 0.01 | phenytoin human nonlinear |
738 | 1 | 0.01 | nortestosterone (net) and testosteron co... |
739 | 1 | 0.01 | diffrance between recent and traditiona ... |
740 | 1 | 0.01 | cassia occidentalis pdf |
741 | 1 | 0.01 | antimicrobial disc for children and preg... |
742 | 1 | 0.01 | plant extrcts against mdr |
743 | 1 | 0.01 | baillus micro organism packing in table... |
744 | 1 | 0.01 | http://www.tjpr.org/vol13_no10/2014_13_1... |
745 | 1 | 0.01 | eudragit rspo ir spectra |
746 | 1 | 0.01 | idu 2009 ethnobotany reference |
747 | 1 | 0.01 | incidence rate snake bite nigeria |
748 | 1 | 0.01 | antimicrobial effect euphorbia+pdf |
749 | 1 | 0.01 | antimicrobial activity of ocimum basilic... |
750 | 1 | 0.01 | which is the most effective toothpaste i... |
751 | 1 | 0.01 | what is validation for phama product |
752 | 1 | 0.01 | peflotab and pregnancy |
753 | 1 | 0.01 | suaeda japonica |
754 | 1 | 0.01 | pipper croctom |
755 | 1 | 0.01 | transdermal penetration enhancers |
756 | 1 | 0.01 | tropic pharma |
757 | 1 | 0.01 | http://www.tjpr.org/vol13_no9/2014_13_9_... |
758 | 1 | 0.01 | fluoride extraction in toothpaste;pdf |
759 | 1 | 0.01 | oroki herbal for weight loss |
760 | 1 | 0.01 | piper crocatum leaves |
761 | 1 | 0.01 | antipyretic experiment?q=antipyretic exp... |
762 | 1 | 0.01 | penetration enhancer with probabal mecha... |
763 | 1 | 0.01 | time delay in pharmacy |
764 | 1 | 0.01 | c3 and c4 low |
765 | 1 | 0.01 | about tea in pdf dounload |
766 | 1 | 0.01 | advantages of gold nanoparticles |
767 | 1 | 0.01 | chloromphenicol eye drop procedure |
768 | 1 | 0.01 | multi unit particulate system |
769 | 1 | 0.01 | malaria vaccines challengs |
770 | 1 | 0.01 | malaria vaccines development limitation |
771 | 1 | 0.01 | http://www.tjpr.org/vol8_no3/2009_8_3_1_... |
772 | 1 | 0.01 | http://www.tjpr.org/vol11_no5/2012_11_5_... |
773 | 1 | 0.01 | journal of chemical and pharmaceutical r... |
774 | 1 | 0.01 | prevalence of diabetes among smokers |
775 | 1 | 0.01 | multi unit particulate system article |
776 | 1 | 0.01 | nabil qaid m al hajj |
777 | 1 | 0.01 | &ptb=006b5bae-2576-4b81-af3f-5e0439b4316... |
778 | 1 | 0.01 | validation process in pharmaceutical ind... |
779 | 1 | 0.01 | 9. mohammed gulzar ahmed ., “ formulat... |
780 | 1 | 0.01 | analgesic and antipyretic effect/herbal ... |
781 | 1 | 0.01 | pegylation of interferon and e.coli |
782 | 1 | 0.01 | psychopathology and marijuana |
783 | 1 | 0.01 | delayed release pellets technology |
784 | 1 | 0.01 | assay of mefenamic acid |
785 | 1 | 0.01 | association study of polymorphism rs5860... |
786 | 1 | 0.01 | hunteria umbellata seeds in maharashtra |
787 | 1 | 0.01 | artivcle on development of immediate rel... |
788 | 1 | 0.01 | antidiarrheal journal pdf |
789 | 1 | 0.01 | annexin v fitc apoptosis pharmingen |
790 | 1 | 0.01 | artemisinin reactions |
791 | 1 | 0.01 | journal interaction teophylin with salbu... |
792 | 1 | 0.01 | how to find the ratio of guar gum in col... |
793 | 1 | 0.01 | impact of waiting time on dispensing of ... |
794 | 1 | 0.01 | antibacterial activity of medicinal plan... |
795 | 1 | 0.01 | the statement of professional standard a... |
796 | 1 | 0.01 | studies on telfairia occidentalis (flute... |
797 | 1 | 0.01 | interlukin biomarker predectors on ant... |
798 | 1 | 0.01 | optimum breaking point of suppository |
799 | 1 | 0.01 | impact of tea on human health |
800 | 1 | 0.01 | sabah snake grass flavonoids and alkanoi... |
801 | 1 | 0.01 | benefits of drug formulation in micropel... |
802 | 1 | 0.01 | carica papaya linn simple procedure of m... |
803 | 1 | 0.01 | anti-microbial of sabah snake grass (pdf... |
804 | 1 | 0.01 | "protein nanoparticles for drug delivery... |
805 | 1 | 0.01 | assessment of the pharmacist knowledge a... |
806 | 1 | 0.01 | glutaraldehyde formulation |
807 | 1 | 0.01 | fenugreek for skin ageing |
808 | 1 | 0.01 | http://www.tjpr.org/vol13_no10/2014_13_1... |
809 | 1 | 0.01 | stevia antibacterial |
810 | 1 | 0.01 | research abstract on suppositories |
811 | 1 | 0.01 | podophyllum hexandrumanalytical method |
812 | 1 | 0.01 | plga based nanoparticles for oral insuli... |
813 | 1 | 0.01 | quetiapine fumarate nano suspension.pdf |
814 | 1 | 0.01 | layer by layer alginate chitosan coated ... |
815 | 1 | 0.01 | house dust mite acaricidal mortalityã€... |
816 | 1 | 0.01 | journal of pharmacy research 4.12 (2011)... |
817 | 1 | 0.01 | paracetamol sustain release microspheres |
818 | 1 | 0.01 | allintitle:viral apoptosis filetype:pdf |
819 | 1 | 0.01 | uji toksisitas akut echinacea |
820 | 1 | 0.01 | synthesis of gold nanoparticles by chemi... |
821 | 1 | 0.01 | validation in drug manufacture |
822 | 1 | 0.01 | mail mepl.org loc:us |
823 | 1 | 0.01 | new drug for treatment of leishmaniasis ... |
824 | 1 | 0.01 | the responsibility of pharmacists in goo... |
825 | 1 | 0.01 | journal formulation syrup extract |
826 | 1 | 0.01 | intervention diabetes in malaysia |
827 | 1 | 0.01 | garg r 2008 progress in controlled |
828 | 1 | 0.01 | hkang@kku.ac.kr ä¸ç’° 852 |
829 | 1 | 0.01 | women's health in developing countries |
830 | 1 | 0.01 | complet validation in pharmaceutical ind... |
831 | 1 | 0.01 | pdf file of drug tablet |
832 | 1 | 0.01 | making biofuel from azolla |
833 | 1 | 0.01 | multiparticulate systems |
834 | 1 | 0.01 | ciprofloxacin solubility |
835 | 1 | 0.01 | studies on patient wait time in the hosp... |
836 | 1 | 0.01 | review article on fast dissolving tablet... |
837 | 1 | 0.01 | sublingual tablets lyophilization |
838 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
839 | 1 | 0.01 | tropical journal of pharmaceutical |
840 | 1 | 0.01 | process control issues in pharmaceutical... |
841 | 1 | 0.01 | polymer solvent coating |
842 | 1 | 0.01 | treatment of brucellosis pdf |
843 | 1 | 0.01 | malnutrition amongst under-five years ch... |
844 | 1 | 0.01 | pdf files on trifelaria occidentalis |
845 | 1 | 0.01 | community pharmacy practice regulations ... |
846 | 1 | 0.01 | antipyretics pdf file |
847 | 1 | 0.01 | arjun patra et al., (2009) have studied ... |
848 | 1 | 0.01 | a stability indicating method |
849 | 1 | 0.01 | is prajapati is differ from bhatia pr n... |
850 | 1 | 0.01 | dietric antidiarrheal drug pdf |
851 | 1 | 0.01 | hepatoprotective effect of ficus deltoid... |
852 | 1 | 0.01 | &ptb=c84472fd-6baa-4110-8afe-ef8aa95b7bd... |
853 | 1 | 0.01 | tropical nsaid drugs |
854 | 1 | 0.01 | stahpylococcus aureus is the major cause... |
855 | 1 | 0.01 | phc pharmacy policies pdf |
856 | 1 | 0.01 | job vecancies in ikot ekpene road uyo ak... |
857 | 1 | 0.01 | importance of low c4 than c3 |
858 | 1 | 0.01 | nutmeg causes high cholesterol triglycer... |
859 | 1 | 0.01 | journal of pharmacy research manuscript ... |
860 | 1 | 0.01 | concentration of natural gums used in co... |
861 | 1 | 0.01 | pharmaceutical process validation pdf |
862 | 1 | 0.01 | canthin |
863 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
864 | 1 | 0.01 | dermal delivery enhancers |
865 | 1 | 0.01 | dosage form options available for for fo... |
866 | 1 | 0.01 | response surface methodology (rsm) chito... |
867 | 1 | 0.01 | surfactant enhanced release pdf |
868 | 1 | 0.01 | how to make a cbemical transdermal to th... |
869 | 1 | 0.01 | formulation and evolution of tramadol hc... |
870 | 1 | 0.01 | gip=-0-pp |
871 | 1 | 0.01 | falodun a, siraj r. 2009. gc-ms analysis... |
872 | 1 | 0.01 | formulation and evaluation of beta cyclo... |
873 | 1 | 0.01 | cordelia onanuga niprd |
874 | 1 | 0.01 | antibacterial activity of plumeria rubra... |
875 | 1 | 0.01 | odt absorbtion |
876 | 1 | 0.01 | nanostructured lipid carriers |
877 | 1 | 0.01 | pharmaceutical research 6(11 |
878 | 1 | 0.01 | polymer which prevent drug in liver pdf |
879 | 1 | 0.01 | development and validation of a new rp-h... |
880 | 1 | 0.01 | boerhaavia hypocholestremic mg/kg |
881 | 1 | 0.01 | validation in pharma pdf |
882 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
883 | 1 | 0.01 | process validation record review artical |
884 | 1 | 0.01 | jurnal sustained release gastroretentive... |
885 | 1 | 0.01 | reduced c3 and c4 level |
886 | 1 | 0.01 | purification of interferon beta1b by fpl... |
887 | 1 | 0.01 | chitosan coated liposome |
888 | 1 | 0.01 | assay for hepatoprotective drugs |
889 | 1 | 0.01 | faculty of basic medical science in ago ... |
890 | 1 | 0.01 | decreased c3 complement and nephritis |
891 | 1 | 0.01 | eudragit rl 100 microspheres |
892 | 1 | 0.01 | http://www.tjpr.org/vol11_no2/index.php |
893 | 1 | 0.01 | journal of tropical pharma |
894 | 1 | 0.01 | ifeanyi chiazor |
895 | 1 | 0.01 | knowledge questionnaire on diabetes mell... |
896 | 1 | 0.01 | drug interaction anhydrous theophylline ... |
897 | 1 | 0.01 | flavonoides e. colis application |
898 | 1 | 0.01 | gastro retentive drug delivry of raniti... |
899 | 1 | 0.01 | sultan ayesh mohammed saghir |
900 | 1 | 0.01 | process control issues in pharmaceutical... |
901 | 1 | 0.01 | books;nanotechnology as drug delivery sy... |
902 | 1 | 0.01 | content |
903 | 1 | 0.01 | transdermal chemicals |
904 | 1 | 0.01 | success rate in pleural tb |
905 | 1 | 0.01 | mohammed gulzar ahmed et al, formulation... |
906 | 1 | 0.01 | pdf file for capsule drug |
907 | 1 | 0.01 | on average how long is the wait at a pha... |
908 | 1 | 0.01 | clinical trials ivermectin and clorsulon |
909 | 1 | 0.01 | reaearch on antibacteria activity of se... |
910 | 1 | 0.01 | cleistopholis+pdf |
911 | 1 | 0.01 | solid lipid nano particles high pressure... |
912 | 1 | 0.01 | research paper on neuroinflammation on h... |
913 | 1 | 0.01 | study on correlation between cyp2d6*10 g... |
914 | 1 | 0.01 | dimethyl sulphoxide is commonly used as ... |
915 | 1 | 0.01 | eudragit rs and rl different |
916 | 1 | 0.01 | fast dissolving tablets absorbs from ora... |
917 | 1 | 0.01 | statement of professional standards in p... |
918 | 1 | 0.01 | why c3 level higher than c4 |
919 | 1 | 0.01 | presriptions waiting |
920 | 1 | 0.01 | pdf orthodox and traditional medicine wh... |
921 | 1 | 0.01 | soheyla honary.effect of zetapotential o... |
922 | 1 | 0.01 | http://www.tjpr.org/vol2%20no1/odeniyi.p... |
923 | 1 | 0.01 | c3/c4 complement readings.lupus |
924 | 1 | 0.01 | cholesterol and ctab on gold nanoparticl... |
925 | 1 | 0.01 | lipitor dissolution |
926 | 1 | 0.01 | journal of paraffin liquid |
927 | 1 | 0.01 | mucoadhesive polymers review pdf |
928 | 1 | 0.01 | immunoflorescence |
929 | 1 | 0.01 | green tea composition, consumption, and ... |
930 | 1 | 0.01 | http://www.tjpr.org/vol13_no6/2014_13_6_... |
931 | 1 | 0.01 | can transdermal meds penetrate to subcut... |
932 | 1 | 0.01 | g6pd deficiency |
933 | 1 | 0.01 | knowledge assesment of community pharmac... |
934 | 1 | 0.01 | journal tramadol sustained release pdf |
935 | 1 | 0.01 | journals on pharmaceutical lotions |
936 | 1 | 0.01 | patient wait times in pharmacy |
937 | 1 | 0.01 | uses of artocarpus chama |
938 | 1 | 0.01 | tropical journal |
939 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
940 | 1 | 0.01 | magnesium stearate |
941 | 1 | 0.01 | low complement c3 and c4 lupus |
942 | 1 | 0.01 | procedure for disintegration of supposit... |
943 | 1 | 0.01 | role of biotechnology in medicinal plant... |
944 | 1 | 0.01 | c3 c4 |
945 | 1 | 0.01 | bareillytodeilltiam. |
946 | 1 | 0.01 | evaluation of microspheres |
947 | 1 | 0.01 | data related to internet usage 2014 |
948 | 1 | 0.01 | effect of leaf extract of on alcohol ind... |
949 | 1 | 0.01 | gold nanoparticles synthesis |
950 | 1 | 0.01 | http://www.tjpr.org/vol1%20no2/akerele12... |
951 | 1 | 0.01 | validation batch pharma |
952 | 1 | 0.01 | sta rx 1500 |
953 | 1 | 0.01 | urea penetration enhancer |
954 | 1 | 0.01 | formulation and evaluation of fast disso... |
955 | 1 | 0.01 | citing articles from tropical journal of... |
956 | 1 | 0.01 | nanoencapsulation, liposome, layer, coat |
957 | 1 | 0.01 | gynura segetum hypertension pdf |
958 | 1 | 0.01 | detection of chloramphenicol,uv-vis |
959 | 1 | 0.01 | commercial medicinal plants in nigeria f... |
960 | 1 | 0.01 | assay of promethazine hydrochloride. wit... |
961 | 1 | 0.01 | 9. mohammed gulzar ahmed ., “ formulat... |
962 | 1 | 0.01 | clinical symptoms of brucellosis in huma... |
963 | 1 | 0.01 | http://www.tjpr.org/vol13_no10/2014_13_1... |
964 | 1 | 0.01 | http://www.tjpr.org/vol12_no6/2013_12_6_... |
965 | 1 | 0.01 | kenechukwu diobi |
966 | 1 | 0.01 | formulation and evaluation of sustained... |
967 | 1 | 0.01 | challenges in traditional medicine |
968 | 1 | 0.01 | bioequvlance study of nitrendipine miros... |
969 | 1 | 0.01 | boerhaavia diffusa dosage |
970 | 1 | 0.01 | south african guide to good manufacturin... |
971 | 1 | 0.01 | pvp and peg used synthesis on nanopartic... |
972 | 1 | 0.01 | simultaneous determination of ezetimibe ... |
973 | 1 | 0.01 | the limits of bacterial contamination gi... |
974 | 1 | 0.01 | mri images carbamazepine toxcity of live... |
975 | 1 | 0.01 | how to prepare scanning electron microsc... |
976 | 1 | 0.01 | hypoglycemic hypolipidemic antioxidant o... |
977 | 1 | 0.01 | advantages and disadvantages of nanopart... |
978 | 1 | 0.01 | a method for preparing intermediate of a... |
979 | 1 | 0.01 | furosemide ftir |
980 | 1 | 0.01 | nifedipine microspheres pdf |
981 | 1 | 0.01 | pdf of about tea |
982 | 1 | 0.01 | physical process of tableting |
983 | 1 | 0.01 | property of metronidazole |
984 | 1 | 0.01 | nitroblue tetrazolium triton x-100 difor... |
985 | 1 | 0.01 | ethanol palm frond extract effect on sta... |
986 | 1 | 0.01 | microsponge dds pdf |
987 | 1 | 0.01 | characteristics of metronidazole |
988 | 1 | 0.01 | current pharmaceutical validation strate... |
989 | 1 | 0.01 | comparison of artesunate suppository and... |
990 | 1 | 0.01 | questionaire based survey study for side... |
991 | 1 | 0.01 | pharmacy journals with impact factor |
992 | 1 | 0.01 | preparation pharmacy of chitosan irradi... |
993 | 1 | 0.01 | pharmaceutical process validation an ove... |
994 | 1 | 0.01 | pharma guideline of south africa for pro... |
995 | 1 | 0.01 | sesamum indicum used in fast dissolving ... |
996 | 1 | 0.01 | review on nanoparticles |
997 | 1 | 0.01 | tropical journal of pharmaceutical r... |
998 | 1 | 0.01 | 4a37d115147c32b9262af6d1564afb6c |
999 | 1 | 0.01 | doxorubicin hplc protocol |
1000 | 1 | 0.01 | antidiarrheal activity of the ethyl acet... |
1001 | 1 | 0.01 | analgesics and antipyretics pdf |
1002 | 1 | 0.01 | tablet sold in ghana |
1003 | 1 | 0.01 | r beesoo sponge |
1004 | 1 | 0.01 | urtica dioica and cancer |
1005 | 1 | 0.01 | tooth powder formulation pdf |
1006 | 1 | 0.01 | gold oxide nanoparticles in pdf |
1007 | 1 | 0.01 | v.j.mohanraj,y.chen,trop.j.pharm.res.,5,... |
1008 | 1 | 0.01 | triclosan toothpaste brands |
1009 | 1 | 0.01 | alstonia boonei pdf |
1010 | 1 | 0.01 | homogenisation of pharmaceutical gels an... |
1011 | 1 | 0.01 | how can i get new equipment in formulati... |
1012 | 1 | 0.01 | http://www.tjpr.org/vol13_no10/2014_13_1... |
1013 | 1 | 0.01 | pdf on nanoparticles |
1014 | 1 | 0.01 | phloroglucinol "first pass" |
1015 | 1 | 0.01 | pharmaceutical approaches and advancemen... |
1016 | 1 | 0.01 | one day experience as a doctor |
1017 | 1 | 0.01 | gelatin microsphere |
1018 | 1 | 0.01 | lag time in transdermal drug delivery |
1019 | 1 | 0.01 | hyperlipidemia flavonoids |
1020 | 1 | 0.01 | microbial contamination cosmetics pr |
1021 | 1 | 0.01 | tropical journal pharmaceutical research... |
1022 | 1 | 0.01 | solid lipid nanoparticles in skin treatm... |
1023 | 1 | 0.01 | proniosomal formualtion of tuberculsis d... |
1024 | 1 | 0.01 | uses of acanthus montanus |
1025 | 1 | 0.01 | allicin protects against lipopolysacchar... |
1026 | 1 | 0.01 | alternative method colorimetry |
1027 | 1 | 0.01 | what is solid state media in marine acti... |
1028 | 1 | 0.01 | super case ii transport drug release |
1029 | 1 | 0.01 | research articles on proniosomes |
1030 | 1 | 0.01 | filetype:pdf relation of nanocomposite a... |
1031 | 1 | 0.01 | how to become a pharmacist in macau |
1032 | 1 | 0.01 | pdf skin permeability |
1033 | 1 | 0.01 | phenolic content and antioxidant activit... |
1034 | 1 | 0.01 | abdel hamid zaki |
1035 | 1 | 0.01 | antibacterial efeect of plant extract pd... |
1036 | 1 | 0.01 | www.transdermal patche of ondansetron hy... |
1037 | 1 | 0.01 | what are the benefit of pharmaceutical c... |
1038 | 1 | 0.01 | lethal dose of alstonia boonei on mice(... |
1039 | 1 | 0.01 | brucellosis in pregnancy pdf |
1040 | 1 | 0.01 | cefuroxime axetil microspheres pdf |
1041 | 1 | 0.01 | c4 complement 12 |
1042 | 1 | 0.01 | block copolymer micelle template |
1043 | 1 | 0.01 | artificial intelligence in pharmaceutica... |
1044 | 1 | 0.01 | adverse events during internship |
1045 | 1 | 0.01 | uriolithiasis inalbino rabbits pdf |
1046 | 1 | 0.01 | sle c3 c4 |
1047 | 1 | 0.01 | vinodh rajangam |
1048 | 1 | 0.01 | how to dry solvents pdf |
1049 | 1 | 0.01 | formulation carbopol gel pdf |
1050 | 1 | 0.01 | effect of tectoridin on analysis of live... |
1051 | 1 | 0.01 | determination of mic and mbc |
1052 | 1 | 0.01 | enterobacter antibiotic resistance uti p... |
1053 | 1 | 0.01 | pdf of hospital and cummunity pharmacy |
1054 | 1 | 0.01 | paracetamol tablets tensile strength |
1055 | 1 | 0.01 | spectrophotometric determination of chlo... |
1056 | 1 | 0.01 | ethanolic extract of sida acuta 4 d trea... |
1057 | 1 | 0.01 | drug distribution to tumor tissue after ... |
1058 | 1 | 0.01 | what is the future of heated transdermal... |
1059 | 1 | 0.01 | ampicillin and cloxacillin dose perti kg |
1060 | 1 | 0.01 | detail of qaulification of pharma |
1061 | 1 | 0.01 | drug carrier pdf |
1062 | 1 | 0.01 | journal formulation in toothpaste sodium... |
1063 | 1 | 0.01 | health benefits of tea consumption pdf |
1064 | 1 | 0.01 | ikechukwuonyishi@yahoo.com |
1065 | 1 | 0.01 | dextrate manufacture |
1066 | 1 | 0.01 | functions of phamacy in nigeria |
1067 | 1 | 0.01 | multiple emulsion experimental design op... |
1068 | 1 | 0.01 | research papers of in vitro anthelmintic... |
1069 | 1 | 0.01 | tropical journal of pharmaceutical reser... |
1070 | 1 | 0.01 | tropical j pharm res |
1071 | 1 | 0.01 | validated process |
1072 | 1 | 0.01 | drug distribution in human body by mathe... |
1073 | 1 | 0.01 | c3 et c4 lab markers |
1074 | 1 | 0.01 | antipyretic pdf |
1075 | 1 | 0.01 | ampiclox is consist of what |
1076 | 1 | 0.01 | c 3 c 4 |
1077 | 1 | 0.01 | nanoparticles drug delivery system pdf |
1078 | 1 | 0.01 | khaya gum in drug delivery system |
1079 | 1 | 0.01 | method of assaying the histopathology of... |
1080 | 1 | 0.01 | suaeda asparagoides monograph |
1081 | 1 | 0.01 | prevalence hepatitis b malaysia |
1082 | 1 | 0.01 | nzekwe ifeanyi pharmaceutics |
1083 | 1 | 0.01 | pdf of sod antioxidant activity |
1084 | 1 | 0.01 | low c4 and positive ana nephritis |
1085 | 1 | 0.01 | nef hiv inhibitor |
1086 | 1 | 0.01 | how to diagnosis silver nanoparticles ... |
1087 | 1 | 0.01 | gentalek injection |
1088 | 1 | 0.01 | how important medicinal plants foe human |
1089 | 1 | 0.01 | tgy medium used in marine actinomycetes |
1090 | 1 | 0.01 | tropical journal of pharmaceutical reses... |
1091 | 1 | 0.01 | tpo positive history of ana low c3 c4 co... |
1092 | 1 | 0.01 | skin permeation enhancers |
1093 | 1 | 0.01 | tea chemical properties in pdf |
1094 | 1 | 0.01 | non aqueous titration of ciprofloxacin |
1095 | 1 | 0.01 | http://www.tjpr.org/jmanager/manuscript/... |
1096 | 1 | 0.01 | kreuter j. nanoparticles. in: swarbrick ... |
1097 | 1 | 0.01 | preparation of doxycycline carbomer gel |
1098 | 1 | 0.01 | simvastatin merck index solubility |
1099 | 1 | 0.01 | carica papaya leaves extract\pdf |
1100 | 1 | 0.01 | antidiarrheal activity of the ethyl acet... |
1101 | 1 | 0.01 | can gentamicin injection be given with v... |
1102 | 1 | 0.01 | effects of patient long waiting time in ... |
1103 | 1 | 0.01 | detecting bpa in drinking bottles |
1104 | 1 | 0.01 | formulation of toothpaste |
1105 | 1 | 0.01 | high fat diet icr mice |
1106 | 1 | 0.01 | functional coating solution preparation |
1107 | 1 | 0.01 | gold nanomaterials in cancer pdf |
1108 | 1 | 0.01 | filetype:pdf cynara sclymus |
1109 | 1 | 0.01 | factor of orodispersible tablets |
1110 | 1 | 0.01 | formulation tablet simvastatin.using bet... |
1111 | 1 | 0.01 | analgesic herbs pdf |
1112 | 1 | 0.01 | preparation of gold nanoparticles using ... |
1113 | 1 | 0.01 | rai dore in english means |
1114 | 1 | 0.01 | breast cancer with nanogold saoudite |
1115 | 1 | 0.01 | anti-diarrhea and anti-oxidant propertie... |
1116 | 1 | 0.01 | cloxacillin powder formulation |
1117 | 1 | 0.01 | ph of pyrimethamine |
1118 | 1 | 0.01 | journal dentification of chloramphenicol... |
1119 | 1 | 0.01 | medical biochemistry uniben |
1120 | 1 | 0.01 | types of validation in pharma pdf |
1121 | 1 | 0.01 | prevalence and incidence of hepatitis b ... |
1122 | 1 | 0.01 | achillea millefolium aqueous extract doe... |
1123 | 1 | 0.01 | partition coefficient paracetamol in vit... |
1124 | 1 | 0.01 | john donnie ramos cancer |
1125 | 1 | 0.01 | c3 serum |
1126 | 1 | 0.01 | brucellosis treatment pdf |
1127 | 1 | 0.01 | evaluation of pharmaceutical solutions |
1128 | 1 | 0.01 | ursolic acid leishmania |
1129 | 1 | 0.01 | pharmaceuticals that bind to gold nanopa... |
1130 | 1 | 0.01 | asparaginase production by solid state f... |
1131 | 1 | 0.01 | aspect of microbial quality of some milk... |
1132 | 1 | 0.01 | effect of paracetamol on liver catalase ... |
1133 | 1 | 0.01 | control release in gastro retentive drug... |
1134 | 1 | 0.01 | antidiabetic property of telfairia occid... |
1135 | 1 | 0.01 | nanoparticles and drug delivery system |
1136 | 1 | 0.01 | microcrystal cellulose hcl 2.5 n 100 c 1... |
1137 | 1 | 0.01 | neuroprotective effects of glycolipids |
1138 | 1 | 0.01 | oral disolving tablet |
1139 | 1 | 0.01 | cancer treating nanoparticle synthesis u... |
1140 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
1141 | 1 | 0.01 | troical journal of pharmaceutical resear... |
1142 | 1 | 0.01 | pharmacy practice in nigeria |
1143 | 1 | 0.01 | positive ana normal c3 c4 |
1144 | 1 | 0.01 | suppositorie oil formulation pdf |
1145 | 1 | 0.01 | stylissa spp |
1146 | 1 | 0.01 | the influence of the molecular weight of... |
1147 | 1 | 0.01 | jurkat sirna transfection |
1148 | 1 | 0.01 | iron deficiency anemia |
1149 | 1 | 0.01 | jain c.p. preparation and characterizati... |
1150 | 1 | 0.01 | http://www.tjpr.org/vol13_no10/2014_13_1... |
1151 | 1 | 0.01 | http://www.tjpr.org/vol7_no3/939_dey.pdf |
1152 | 1 | 0.01 | low c4 leves kideny disease |
1153 | 1 | 0.01 | measuring c3 and c4 |
1154 | 1 | 0.01 | pdf on medicinal plants used for diarrhe... |
1155 | 1 | 0.01 | suppositories (oily bases) experiment |
1156 | 1 | 0.01 | the evolution of pharmacist practice in ... |
1157 | 1 | 0.01 | microbial testing for live active cultur... |
1158 | 1 | 0.01 | http://www.tjpr.org/vol6_no3/638sharma.p... |
1159 | 1 | 0.01 | paraffin ointment theory |
1160 | 1 | 0.01 | pharmacological and other bioactivities ... |
1161 | 1 | 0.01 | calcium chlorid hairy root |
1162 | 1 | 0.01 | what ispharmaceutical validation |
1163 | 1 | 0.01 | uae hospital pharmacy setting |
1164 | 1 | 0.01 | control drug delivery system pdf |
1165 | 1 | 0.01 | disadvantage of using colorimetric metho... |
1166 | 1 | 0.01 | how to test an ethanol extract on an org... |
1167 | 1 | 0.01 | http://www.tjpr.org/vol7_no3/7310_sreeni... |
1168 | 1 | 0.01 | fluoroquinolones antidote |
1169 | 1 | 0.01 | enhancer agent |
1170 | 1 | 0.01 | difference between ampicillin and ciprof... |
1171 | 1 | 0.01 | "high fat diet" mouse acarbose |
1172 | 1 | 0.01 | what happened if my c reactive protien i... |
1173 | 1 | 0.01 | c3c4 assay in sle |
1174 | 1 | 0.01 | arung, wood of sukun |
1175 | 1 | 0.01 | common side effect in community pharmacy |
1176 | 1 | 0.01 | penetration of drug through skin |
1177 | 1 | 0.01 | oleic acid penetration enhancer |
1178 | 1 | 0.01 | paracetamol tablet tensile strength |
1179 | 1 | 0.01 | indication for taking yoyo bitters |
1180 | 1 | 0.01 | polycaprolactone microparticle blends wi... |
1181 | 1 | 0.01 | filetype:pdf chronotherapeutics |
1182 | 1 | 0.01 | diluting ethanol for agar plates |
1183 | 1 | 0.01 | serum complement c3 79 |
1184 | 1 | 0.01 | sperm |
1185 | 1 | 0.01 | lou zx, wang hx, zhu s, zhang m, gao y,... |
1186 | 1 | 0.01 | low c4 and thrombocytopenia |
1187 | 1 | 0.01 | http://www.tjpr.org/jmanager/manuscript/... |
1188 | 1 | 0.01 | activity of tooth paste on oral organism... |
1189 | 1 | 0.01 | doe complement levels dip with nephritis... |
1190 | 1 | 0.01 | mechanisms of drug solution absorbtion t... |
1191 | 1 | 0.01 | oven dried microcapsules |
1192 | 1 | 0.01 | protocol for the antimicrobial activity ... |
1193 | 1 | 0.01 | serum c3 |
1194 | 1 | 0.01 | &si=cm-y942mz8ecfuthtaodv1uasq |
1195 | 1 | 0.01 | studies done in boerhavia diffusa |
1196 | 1 | 0.01 | www.pharma validation.com |
1197 | 1 | 0.01 | pdf black tea benefit |
1198 | 1 | 0.01 | low c3 and c4 and liver in adult |
1199 | 1 | 0.01 | multiparticulate coating |
1200 | 1 | 0.01 | prakash et al., 2007 |
1201 | 1 | 0.01 | pharmaceutical journal research |
1202 | 1 | 0.01 | purpose for validationcycle development |
1203 | 1 | 0.01 | nanoparticles review articles |
1204 | 1 | 0.01 | http://www.tjpr.org/vol13_no6/2014_13_6_... |
1205 | 1 | 0.01 | knowledge about diabetes among diabetic ... |
1206 | 1 | 0.01 | alza e trans |
1207 | 1 | 0.01 | how to make vataksm |
1208 | 1 | 0.01 | phytochemical screenig and antioxidant a... |
1209 | 1 | 0.01 | penetration enhancer of essensial oil pd... |
1210 | 1 | 0.01 | research paper on papaya in pdf |
1211 | 1 | 0.01 | araoye 2004 |
1212 | 1 | 0.01 | the role of pharmacist in promoting and ... |
1213 | 1 | 0.01 | pharaceutical equipmentverified in the p... |
1214 | 1 | 0.01 | research articles on activities of cari... |
1215 | 1 | 0.01 | selection of extraction solvent for saba... |
1216 | 1 | 0.01 | drug nantechnology wikipiida |
1217 | 1 | 0.01 | challenges facing herbal medicine practi... |
1218 | 1 | 0.01 | antiglycation ghulam abbas |
1219 | 1 | 0.01 | calendula officinalis tissue culture |
1220 | 1 | 0.01 | faculty directory +962 "email |
1221 | 1 | 0.01 | gold nanoparticles : synthesis and appli... |
1222 | 1 | 0.01 | evaluation of some methods for preparing... |
1223 | 1 | 0.01 | chemical transdermal drug delivery |
1224 | 1 | 0.01 | benefits of pharmaceutical care |
1225 | 1 | 0.01 | role of a pharmacist in primary health c... |
1226 | 1 | 0.01 | rai dore plant |
1227 | 1 | 0.01 | what mean by serum c3 and c4 |
1228 | 1 | 0.01 | sle flare and complement levels |
1229 | 1 | 0.01 | aminophylline suppository |
1230 | 1 | 0.01 | post evolution test for buccal tablet?q=... |
1231 | 1 | 0.01 | novel mucoadhesive drug delivery system |
1232 | 1 | 0.01 | pd fileon hypertension |
1233 | 1 | 0.01 | microsponge preparation |
1234 | 1 | 0.01 | tropical journal of pharma |
1235 | 1 | 0.01 | simvastatin odt dissolution media |
1236 | 1 | 0.01 | validation pharmaceutical quality assura... |
1237 | 1 | 0.01 | &si=cizu8yr_3cecfvcnjgoddrcana |
1238 | 1 | 0.01 | &si=d2d |
1239 | 1 | 0.01 | www.wp.pl magda szymanska biaystok?q=www... |
1240 | 1 | 0.01 | kushwaha swtantra camptothecin |
1241 | 1 | 0.01 | what is penetrat medicine uses |
1242 | 1 | 0.01 | floating microspheres of salbutamol |
1243 | 1 | 0.01 | determination of naproxen in plasma by l... |
1244 | 1 | 0.01 | http://www.tjpr.org/vol13_no10/2014_13_1... |
1245 | 1 | 0.01 | opportunities for a pharmacist to become... |
1246 | 1 | 0.01 | research article on cilostazol |
1247 | 1 | 0.01 | makmor bakry |
1248 | 1 | 0.01 | isolation of yeast from milk and milk pr... |
1249 | 1 | 0.01 | men in nigeria talking of their staph au... |
1250 | 1 | 0.01 | term paper on the evolution pharmacist p... |
1251 | 1 | 0.01 | research on suppositories |
1252 | 1 | 0.01 | serum complement c3 c4 |
1253 | 1 | 0.01 | tropical j of pharma sci |
1254 | 1 | 0.01 | åœ¨æ ‡é¢˜: urtica |
1255 | 1 | 0.01 | formulation and evaluation of microspher... |
1256 | 1 | 0.01 | does chloramphenicol eye ointment contai... |
1257 | 1 | 0.01 | controlled drug delivery system pdf |
1258 | 1 | 0.01 | colloidal carriers definition |
1259 | 1 | 0.01 | development of immediate release tablet ... |
1260 | 1 | 0.01 | antioxidant ayoola 2008 |
1261 | 1 | 0.01 | batatasin |
1262 | 1 | 0.01 | avicel 101 |
1263 | 1 | 0.01 | chapter one of phytochemical investigati... |
1264 | 1 | 0.01 | http://www.tjpr.org/vol2_no2/22erhun.pdf |
1265 | 1 | 0.01 | http://www.tjpr.org/ |
1266 | 1 | 0.01 | function of gentalek injection |
1267 | 1 | 0.01 | half life of zerodol |
1268 | 1 | 0.01 | inclusion complexation with beta cyclode... |
1269 | 1 | 0.01 | http://www.tjpr.org/vol8_no4/2009_8_4_1_... |
1270 | 1 | 0.01 | molecular weight of chitosan polymer |
1271 | 1 | 0.01 | carpolobia lutea |
1272 | 1 | 0.01 | artemisinin drug profile pdf |
1273 | 1 | 0.01 | antidiarrheal activities of medicinal pl... |
1274 | 1 | 0.01 | beta cyclodextrin solubility pdf |
1275 | 1 | 0.01 | validity period of mcc gmp inspection |
1276 | 1 | 0.01 | formulation and evaluation of matrix mic... |
1277 | 1 | 0.01 | dmdm hydatoin bacterila resistance |
1278 | 1 | 0.01 | alt,alp,ast level of albino rats |
1279 | 1 | 0.01 | a review on penetration enhancer and mec... |
1280 | 1 | 0.01 | antibacterial effect on klebsiella pneum... |
1281 | 1 | 0.01 | http://www.tjpr.org/vol12_no6/2013_12_6_... |
1282 | 1 | 0.01 | modelling partial pressure out term |
1283 | 1 | 0.01 | pharmaceutical process validation pdf |
1284 | 1 | 0.01 | peflotab, fidson |
1285 | 1 | 0.01 | gatifloxacin antagonism |
1286 | 1 | 0.01 | henk. d. f. h. schallig royal tropical i... |
1287 | 1 | 0.01 | lupus nephritis c4 level |
1288 | 1 | 0.01 | low c3 and c4 |
1289 | 1 | 0.01 | male contraception/pdf |
1290 | 1 | 0.01 | synthese of fe3o4 nanoparticles for drug... |
1291 | 1 | 0.01 | roles of pharmacists in phc ( according ... |
1292 | 1 | 0.01 | process validation of tramadol hydrochlo... |
1293 | 1 | 0.01 | synthesis metformin hcl with ethanol |
1294 | 1 | 0.01 | tropi |
1295 | 1 | 0.01 | what is routine systematic corticosterio... |
1296 | 1 | 0.01 | . methods of controlled release pdf |
1297 | 1 | 0.01 | hanxiao sun |
1298 | 1 | 0.01 | citation of evaluation of the antioxidan... |
1299 | 1 | 0.01 | anticholinesterases au benin |
1300 | 1 | 0.01 | chemistry of drug delivery material pdf |
1301 | 1 | 0.01 | site:" @gmail.com" "diabete suffer" |
1302 | 1 | 0.01 | stability indicating hplc methods |
1303 | 1 | 0.01 | tropical pharma |
1304 | 1 | 0.01 | loratadine nanoparticle |
1305 | 1 | 0.01 | journal uji toksistas internasional |
1306 | 1 | 0.01 | hepatoprotective activity pdf |
1307 | 1 | 0.01 | dioscorea dumetorum au bénin |
1308 | 1 | 0.01 | natural permiation enhancer example |
1309 | 1 | 0.01 | low c3 normal c4 |
1310 | 1 | 0.01 | mercaptoundec amine gold nanoparticle cy... |
1311 | 1 | 0.01 | reserpine isolation steps pdf |
1312 | 1 | 0.01 | serum total protein in wistar rats |
1313 | 1 | 0.01 | sales of anti inflammatory |
1314 | 1 | 0.01 | preparation of mefanamic acid in laborat... |
1315 | 1 | 0.01 | higuchi t, connors ka, phase solubility ... |
1316 | 1 | 0.01 | http://www.tjpr.org |
1317 | 1 | 0.01 | mohammad saleem, uzma saleem |
1318 | 1 | 0.01 | layers of cerebellum in rats |
1319 | 1 | 0.01 | nanoparticle drug synthesis |
1320 | 1 | 0.01 | adsorbent diazepam pdf |
1321 | 1 | 0.01 | what is mean by antifungal activity pdf |
1322 | 1 | 0.01 | steps involved in a validation process o... |
1323 | 1 | 0.01 | effect of compression force on tablet ha... |
1324 | 1 | 0.01 | analysis of satisfaction outpatient phar... |
1325 | 1 | 0.01 | induction of atherosclerosis in rats |
1326 | 1 | 0.01 | fn |
1327 | 1 | 0.01 | c3 c4 tests lupus |
1328 | 1 | 0.01 | advantages of odt |
1329 | 1 | 0.01 | complexes as reducing agents in nanopar... |
1330 | 1 | 0.01 | what is nanoparticles.pdf |
1331 | 1 | 0.01 | types of process validation |
1332 | 1 | 0.01 | research articles on oro dispersible ta... |
1333 | 1 | 0.01 | why is c3 low and c4 normal |
1334 | 1 | 0.01 | mtt assay of extracts woods |
1335 | 1 | 0.01 | drugs purchasing pattern in drugs shop |
1336 | 1 | 0.01 | furosemide spectra ftir |
1337 | 1 | 0.01 | phytochemicals of bombax malabaricum |
1338 | 1 | 0.01 | gold nanoparticles synthesis and applica... |
1339 | 1 | 0.01 | pharma validation pdf |
1340 | 1 | 0.01 | write notes on clinical features of bruc... |
1341 | 1 | 0.01 | tea pdf |
1342 | 1 | 0.01 | signs & symptoms of iron deficiency in t... |
1343 | 1 | 0.01 | studies in benin city assessing the know... |
1344 | 1 | 0.01 | phytochemical screening of herbaceous me... |
1345 | 1 | 0.01 | "validation report" conform template dr... |
1346 | 1 | 0.01 | tropical journal of pharmaceutics |
1347 | 1 | 0.01 | antioxidant glutamate, sod and catalase ... |
1348 | 1 | 0.01 | how to identify poor quality of milk an... |
1349 | 1 | 0.01 | gold nanoparticle synthesis |
1350 | 1 | 0.01 | cyp2d6 gene structure |
1351 | 1 | 0.01 | filetype:pdf heat moisture treatment of ... |
1352 | 1 | 0.01 | what is a role of pharmacist in primary ... |
1353 | 1 | 0.01 | calendulae flos haemolytic activity |
1354 | 1 | 0.01 | brittle factor index pharmaceutical |
1355 | 1 | 0.01 | causes of low serum c3 |
1356 | 1 | 0.01 | in vivo studies of anti diarreal drugs |
1357 | 1 | 0.01 | gastroretentive drug delivery system |
1358 | 1 | 0.01 | importance of dm plant in a pharmaceutic... |
1359 | 1 | 0.01 | doxorubicin hplc uv wavelength |
1360 | 1 | 0.01 | sello d.a factors. |
1361 | 1 | 0.01 | types of eudragits |
1362 | 1 | 0.01 | dr.e.k.i omogbai |
1363 | 1 | 0.01 | bioadhesive drug and tablet abstract pdf |
1364 | 1 | 0.01 | meloxicam tablet formulation |
1365 | 1 | 0.01 | http://www.tjpr.org/vol13_no10/2014_13_1... |
1366 | 1 | 0.01 | journals on the roles of c3 and c4 tests |
1367 | 1 | 0.01 | normal c3 low c4 |
1368 | 1 | 0.01 | progesterone polymorphism melting point ... |
1369 | 1 | 0.01 | http://www.tjpr.org/vol8_no3/2009_8_3_11... |
1370 | 1 | 0.01 | in vitro release |
1371 | 1 | 0.01 | fakhsheena anjum |
1372 | 1 | 0.01 | ethnobotany of ficus of north east india |
1373 | 1 | 0.01 | gold nanomaterials in cancer pdf |
1374 | 1 | 0.01 | microspheres preparation ,method by solv... |
1375 | 1 | 0.01 | mouth dissolving tablets |
1376 | 1 | 0.01 | patient satisfaction in term of waiting ... |
1377 | 1 | 0.01 | tropical journal of pharmaceutical resar... |
1378 | 1 | 0.01 | tropical j pharma |
1379 | 1 | 0.01 | review article of fast dissolving tablet |
1380 | 1 | 0.01 | recent articles on cardiovascular using ... |
1381 | 1 | 0.01 | shape matters in dna nanoparticle therap... |
1382 | 1 | 0.01 | interpreting c3 and c4 |
1383 | 1 | 0.01 | inert matrix and formulation buffer |
1384 | 1 | 0.01 | lupus nephritis and c4 complement level |
1385 | 1 | 0.01 | tectoridin |
1386 | 1 | 0.01 | saira azhar article on need of pharmacis... |
1387 | 1 | 0.01 | mohanjaf v.j and y chen (2006). nanopart... |
1388 | 1 | 0.01 | phytopharmaceuticals pdf |
1389 | 1 | 0.01 | ana + c4 |
1390 | 1 | 0.01 | review on drugs delivary by nano partic... |
1391 | 1 | 0.01 | biodegradable poly (d, l-lactic-co-glyco... |
1392 | 1 | 0.01 | chitosan molecular weight |
1393 | 1 | 0.01 | ved prakash pandey708gmail com |
1394 | 1 | 0.01 | 4d278fda3f330377e3ae1427117bc2a5 |
1395 | 1 | 0.01 | suprecur mp buserelin spray dryer |
1396 | 1 | 0.01 | renal toxic drugs aminoglycoside |
1397 | 1 | 0.01 | use value and relative importance in eth... |
1398 | 1 | 0.01 | journal of pharmaceutical research |
1399 | 1 | 0.01 | formulations rectal pdf |
1400 | 1 | 0.01 | preparation of buccal patches |
1401 | 1 | 0.01 | dioscorea dumetorum |
1402 | 1 | 0.01 | c3 c4 complement studies |
1403 | 1 | 0.01 | chemistry behind transdermal patches |
1404 | 1 | 0.01 | biomedical vs pharmacy which is more sup... |
1405 | 1 | 0.01 | anticonvulsant effect of extract pdf |
1406 | 1 | 0.01 | c3 and c4 in lupus |
1407 | 1 | 0.01 | how dies an altered circulatory system a... |
1408 | 1 | 0.01 | eurycoma longifolia optimization in extr... |
1409 | 1 | 0.01 | http://www.tjpr.org/vol13_no9/2014_13_9_... |
1410 | 1 | 0.01 | cytotoxicity of essential oil of chenopo... |
1411 | 1 | 0.01 | curative test on alstonia boonei(pdf) |
1412 | 1 | 0.01 | c3 deficiency leads to sle |
1413 | 1 | 0.01 | anti fungal activity of trichophyton rub... |
1414 | 1 | 0.01 | c3 low c4 normal |
1415 | 1 | 0.01 | pdf of boerhaavia difusa |
1416 | 1 | 0.01 | multiparticulate drug delivery system |
1417 | 1 | 0.01 | resistant urinary tract microorganisms p... |
1418 | 1 | 0.01 | a research to determine level of knowled... |
1419 | 1 | 0.01 | an |
1420 | 1 | 0.01 | antimicrobial activities of sida acuta e... |
1421 | 1 | 0.01 | a review on mouth dissolving tablet tech... |
1422 | 1 | 0.01 | a review on polymeric nanoparticles?q=a ... |
1423 | 1 | 0.01 | indigenous plant and people journal |
1424 | 1 | 0.01 | incidence of antibiotic resistant patter... |
1425 | 1 | 0.01 | invitro release study of tropical formul... |
1426 | 1 | 0.01 | microbiology of milk and milk products p... |
1427 | 1 | 0.01 | research artical on anticonvulsent activ... |
1428 | 1 | 0.01 | microparticle versus nanoparticle for be... |
1429 | 1 | 0.01 | method of preparing micellar solubilisat... |
1430 | 1 | 0.01 | orodispersiba tablet of meloxicam |
1431 | 1 | 0.01 | how can pharmacist increase involvement ... |
1432 | 1 | 0.01 | definition of a designer nano particle |
1433 | 1 | 0.01 | http://www.tjpr.org/vol13_no10/2014_13_1... |
1434 | 1 | 0.01 | journals on pharmaceutical microbiology |
1435 | 1 | 0.01 | avicel ph 101 |
1436 | 1 | 0.01 | griseofulvin tablet dissolution bp |